NASDAQ:TCDA - Tricida Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $22.59 +0.55 (+2.50 %) (As of 01/16/2019 02:37 AM ET)Previous Close$22.04Today's Range$21.55 - $23.0352-Week Range$21.08 - $40.10Volume260,700 shsAverage Volume181,620 shsMarket Capitalization$978.56 millionP/E RatioN/ADividend YieldN/ABetaN/A ProfileDiscussionAnalyst RatingsChartEarningsInsider TradesInstitutional OwnershipHeadlinesSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Tricida, Inc. operates as a pharmaceutical company. It focuses on the development and commercialization of TRC101, a non-absorbed orally-administered polymer drug that has completed Phase III clinical trials to treat metabolic acidosis in patients with chronic kidney disease. The company was founded in 2013 and is headquartered in South San Francisco, California. Receive TCDA News and Ratings via Email Sign-up to receive the latest news and ratings for TCDA and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NASDAQ Industry Pharmaceutical preparations Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:TCDA Previous Symbol CUSIPN/A Webwww.tricida.com Phone415-429-7800Debt Debt-to-Equity Ratio0.11 Current Ratio12.68 Quick Ratio12.68Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees61 Outstanding Shares42,110,000Market Cap$978.56 million OptionableNot Optionable Tricida (NASDAQ:TCDA) Frequently Asked Questions What is Tricida's stock symbol? Tricida trades on the NASDAQ under the ticker symbol "TCDA." How were Tricida's earnings last quarter? Tricida Inc (NASDAQ:TCDA) posted its quarterly earnings results on Thursday, November, 8th. The company reported ($0.65) earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of ($0.84) by $0.19. View Tricida's Earnings History. When is Tricida's next earnings date? Tricida is scheduled to release their next quarterly earnings announcement on Thursday, February 14th 2019. View Earnings Estimates for Tricida. What price target have analysts set for TCDA? 3 Wall Street analysts have issued 12-month price objectives for Tricida's shares. Their forecasts range from $32.00 to $50.00. On average, they anticipate Tricida's share price to reach $38.6667 in the next twelve months. This suggests a possible upside of 71.2% from the stock's current price. View Analyst Price Targets for Tricida. What is the consensus analysts' recommendation for Tricida? 3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Tricida in the last year. There are currently 2 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Tricida. Has Tricida been receiving favorable news coverage? Media headlines about TCDA stock have trended somewhat positive this week, according to InfoTrie. The research firm identifies negative and positive media coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Tricida earned a news sentiment score of 1.9 on InfoTrie's scale. They also assigned media stories about the company a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an impact on the company's share price in the next few days. Are investors shorting Tricida? Tricida saw a increase in short interest in December. As of December 31st, there was short interest totalling 1,827,972 shares, an increase of 64.2% from the December 14th total of 1,113,350 shares. Based on an average daily volume of 296,733 shares, the days-to-cover ratio is presently 6.2 days. Approximately 6.7% of the shares of the company are short sold. View Tricida's Current Options Chain. Who are some of Tricida's key competitors? Some companies that are related to Tricida include GW Pharmaceuticals PLC- (GWPH), Array Biopharma (ARRY), Taro Pharmaceutical Industries (TARO), Horizon Pharma (HZNP), Evotec (EVTCY), Emergent Biosolutions (EBS), Intercept Pharmaceuticals (ICPT), Agios Pharmaceuticals (AGIO), Ascendis Pharma A/S (ASND), HUTCHISON CHINA/S (HCM), Ligand Pharmaceuticals (LGND), Akcea Therapeutics (AKCA), Blueprint Medicines (BPMC), ACADIA Pharmaceuticals (ACAD) and Ultragenyx Pharmaceutical (RARE). Who are Tricida's key executives? Tricida's management team includes the folowing people: Dr. Gerrit Klaerner, Founder, Pres, CEO & Exec. Director (Age 47)Mr. Geoffrey M. Parker, CFO & Sr. VP (Age 53)Dr. Wilhelm Stahl, Chief Technology Officer & Sr. VP (Age 58)Steffen Pietzke, VP of Fin. & Chief Accounting OfficerJackie Cossmon, VP of Investor Relations & Communications When did Tricida IPO? (TCDA) raised $175 million in an initial public offering (IPO) on Thursday, June 28th 2018. The company issued 10,300,000 shares at $16.00-$18.00 per share. Goldman Sachs, J.P. Morgan and Cowen acted as the underwriters for the IPO. When did the company's lock-up period expire? Tricida's lock-up period expired on Tuesday, December 25th. Tricida had issued 11,700,000 shares in its initial public offering on June 28th. The total size of the offering was $222,300,000 based on an initial share price of $19.00. Since the end of the company's lock-up period, restrictions preventing major shareholders and company insiders from selling shares in the company have been lifted. How do I buy shares of Tricida? Shares of TCDA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Tricida's stock price today? One share of TCDA stock can currently be purchased for approximately $22.59. How big of a company is Tricida? Tricida has a market capitalization of $978.56 million. Tricida employs 61 workers across the globe. What is Tricida's official website? The official website for Tricida is http://www.tricida.com. How can I contact Tricida? Tricida's mailing address is 7000 SHORELINE COURT SUITE 201, SOUTH SAN FRANCISCO CA, 94080. The company can be reached via phone at 415-429-7800 or via email at [email protected] MarketBeat Community Rating for Tricida (NASDAQ TCDA)Community Ranking: 2.0 out of 5 ( )Outperform Votes: 36 (Vote Outperform)Underperform Votes: 52 (Vote Underperform)Total Votes: 88MarketBeat's community ratings are surveys of what our community members think about Tricida and other stocks. Vote "Outperform" if you believe TCDA will outperform the S&P 500 over the long term. Vote "Underperform" if you believe TCDA will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 1/16/2019 by MarketBeat.com StaffFeatured Article: What is the Quick Ratio?